In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Four Key Trends In Pharmaceutical Alliances

Executive Summary

As the worst threats of managed care receded, the industry saw an explosion in the number of available, innovative late-stage drugs, both from biotechs and from mid-sized companies unable to sell them on their own. Genomics and combinatorial chemistry burst onto the R&D scene, generating a huge wealth of targets and compounds. The result has been a sudden return to the roots of the drug industry: finding and selling innovative branded products.
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

IV000506

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel